Table 2 (abstract ABS015) Cohort comparison for a positive stress echocardiogram result
From: Abstracts from the British Society of Echocardiography annual meeting 2023
Positive stress echo | Group 1/2 (N = 1347) | Group 3 (N = 1139) | P-value |
|---|---|---|---|
Participant demographics | |||
Male (%) | 876/1347 (65.0) | 775/1139 (68.0) | 0.11 |
Median age (years) (IQR) | 68 (60–74) | 67 (59–74) |  |
Median BMI (kg/m2) (IQR) | 28.69 (25.6–32.2) | 28.08 (25.1–31.88) |  |
Current smoker (%) | 172/1299 (13.2) | 155/1089 (14.2) | 0.48 |
Ex-smoker (%) | 520/1299 (40.0) | 391/1089 (35.9) | < 0.05 |
Non-smoker (%) | 607/1299 (46.7) | 543/1089 (49.9) | 0.13 |
Hypertension (%) | 721/1347 (53.5) | 681/1134 (60.1) | < 0.01 |
Hypercholesterolaemia (%) | 668/1347 (49.6) | 619/1134 (54.6) | < 0.05 |
Diabetes mellitus (%) | 319/1347 (23.7) | 344/1134 (30.3) | < 0.001 |
Peripheral vascular disease (%) | 57/1347 (4.2) | 24/1134 (2.1) | < 0.001 |
Family history of premature CAD (%) | 65/1347 (4.8) | 409/1134 (36.1) | < 0.001 |
Previous MI (%) | 348/1322 (26.3) | 259/1134 (22.8) | < 0.05 |
Previous PCI (%) | 568/1324 (42.9) | 301/1134 (26.5) | < 0.001 |
Precious CABG (%) | 195/1326 (14.7) | 133/1134 (11.7) | < 0.05 |
Resting RWMA (%) | 483/1344 (35.9) | 253/812 (31.2) | < 0.05 |
Stress echocardiogram details | |||
Exercise (%) | 354/1347 (26.3) | 309/1117 (27.7) | 0.44 |
Pacemaker (%) | 10/1347 (0.7) | 13/1117 (1.2) | 0.28 |
Dobutamine (%) | 990/1347 (73.5) | 795/1117 (71.2) | 0.20 |
Atropine use in DSE (%) | 530/990 (53.5) | 386/795 (48.6) | < 0.05 |
Contrast used | 971/1343 (72.3) | 1026/1127 (91.0) | < 0.001 |
SonoVue (%) | 904/971 (93.1) | 903/1026 (88.0) | < 0.001 |
Luminity (%) | 63/971 (6.5) | 122/1026 (11.9) | < 0.001 |
Other (e.g. Optison) (%) | 4/971 (0.4) | 1/1026 (0.1) | 0.16 |
No contrast (%) | 372/1343 (27.7) | 101/1127 (9.0) | < 0.001 |